EBITDA grew 48% YoY at ₹210 crore, from ₹142 crore in the same quarter last year, marking better profitability.
Revenue grew 7% year over year to ₹3,255 crore, as compared with ₹3,043 crore during the same quarter of last fiscal year
The company’s revenue for the quarter registered an increase of 116% y-o-y to ₹3,457 Crore as compared to ₹1,596 Crore.
Biocon's EBITDA increased by 16% YoY to ₹787 crore, which shows improved operational performance.
The company’s net interest income (NII) witnessed a growth of 2.8% y-o-y to ₹11,417 Crore against ₹11,101 Crore in Q3FY25.
Trump is contemplating further tariffs on China and intends to put tariffs on Canada and Mexico on Saturday.
The company registered a 28% increase in its December quarter’s Asset Under Management (AUM) at ₹3,98,043 Crore.
However, despite excellent performance during the quarter, EBITDA margins declined to 6% in Q3FY25, against 7.1% in Q3FY24.
The company’s revenue for the quarter under review witnessed a growth of 17% y-o-y to ₹4,443 Crore.
To continue with this discussion, here is a broad overview of all the taxes that are applicable to an Indian consumer.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
